clindamycin and flucytosine

clindamycin has been researched along with flucytosine in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19906 (40.00)18.7374
1990's1 (6.67)18.2507
2000's5 (33.33)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, NA; Matin, A; Siddiqui, R; Stins, M; Warhurst, D1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fieker, DH; McHenry, MC1
Hermans, PE; Wilkowske, CJ1
Hussar, DA1
Pohjola-Sintonen, S; Ruutu, P; Tallroth, K1
Moellering, RC; Murray, BE1

Reviews

4 review(s) available for clindamycin and flucytosine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Newer antibacterial and antimycotic drugs. Critical appraisal.
    The Medical clinics of North America, 1978, Volume: 62, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim

1978
New drugs of 1972.
    American journal of pharmacy and the sciences supporting public health, 1973, Volume: 145, Issue:1

    Topics: Acetals; Administration, Topical; Anthelmintics; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Anxiety; Benzazepines; Carboxylic Acids; Clindamycin; Drug Therapy; Flucytosine; Fluorometholone; Fluphenazine; Humans; Hypnotics and Sedatives; Ketosteroids; Megestrol; Pancuronium; Phenyl Ethers; Phosphoric Acids; Prednisolone; Pyrimidines; Thiophenes; Tranquilizing Agents; Vinyl Compounds

1973
Antimicrobial agents in pulmonary infections.
    The Medical clinics of North America, 1980, Volume: 64, Issue:3

    Topics: Aminoglycosides; Amphotericin B; Anti-Infective Agents; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Miconazole; Penicillins; Respiratory Tract Infections; Tetracycline; Vancomycin

1980

Other Studies

11 other study(ies) available for clindamycin and flucytosine

ArticleYear
Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Actins; Amebicides; Amoeba; Animals; Cell Line; Cell Survival; Cycloheximide; Cytochalasin D; Cytoskeleton; Dose-Response Relationship, Drug; Endothelial Cells; Ergosterol; Humans; Ketoconazole

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Septicaemia.
    Scottish medical journal, 1975, Volume: 20, Issue:2

    Topics: Cefazolin; Cephaloridine; Cephalothin; Cephradine; Clindamycin; Drug Resistance, Microbial; Flucytosine; Gentamicins; Humans; Lincomycin; Metronidazole; Sepsis; Shock, Septic; Tobramycin

1975
Actions and uses of antimicrobial agents in the treatment of musculoskeletal infections.
    The Orthopedic clinics of North America, 1975, Volume: 6, Issue:4

    Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bone Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Infections; Lincomycin; Muscular Diseases; Nystatin; Penicillins; Tetracyclines

1975
Hematogenous Candida spondylitis. A case report.
    Acta medica Scandinavica, 1984, Volume: 215, Issue:1

    Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis

1984
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995